0001667959-17-000001.txt : 20170221 0001667959-17-000001.hdr.sgml : 20170220 20170217174035 ACCESSION NUMBER: 0001667959-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170221 DATE AS OF CHANGE: 20170217 EFFECTIVENESS DATE: 20170221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GenomeNext LLC CENTRAL INDEX KEY: 0001667959 IRS NUMBER: 464808018 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-280985 FILM NUMBER: 17622544 BUSINESS ADDRESS: STREET 1: 175 SOUTH 3RD STREET, SUITE 200 CITY: COLUMBUS STATE: OH ZIP: 43215 BUSINESS PHONE: 301-275-8080 MAIL ADDRESS: STREET 1: 175 SOUTH 3RD STREET, SUITE 200 CITY: COLUMBUS STATE: OH ZIP: 43215 D 1 primary_doc.xml X0707 D LIVE 0001667959 GenomeNext LLC 175 SOUTH 3RD STREET, SUITE 200 COLUMBUS OH OHIO 43215 301-275-8080 OHIO None None Limited Liability Company true 2014 James Hirmas c/o GenomeNext LLC 175 South 3rd Street, Suite 200 Columbus OH OHIO 43215 Executive Officer Director Hemant Datta c/o GenomeNext LLC 175 South 3rd Street, Suite 200 Columbus OH OHIO 43215 Director Craig Atkinson c/o GenomeNext LLC 175 South 3rd Street, Suite 200 Columbus OH OHIO 43215 Director Drew Conway c/o GenomeNext LLC 175 South 3rd Street, Suite 200 Columbus OH OHIO 43215 Director Biotechnology Decline to Disclose 06b false 2017-02-03 false true false 0 500000 500000 0 false 5 0 0 0 false GenomeNext LLC /s/ James Hirmas James Hirmas Chief Executive Officer 2017-02-17